SHPH SHUTTLE PHARMACEUTICALS HOLDINGS INC Management Changes 8-K Filing 2025 - Management Change On March 11, 2025, Shuttle Pharmaceuticals appointed Mr. Christopher Cooper as interim co-CEO and entered a consulting agreement with him for $20,000 per month for six months. A press release about this appointment was published on March 12, 2025.Get access to all SEC 8-K filings of the SHUTTLE PHARMACEUTICALS HOLDINGS INC